Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial
Resource Type
Article
Authors
Behringer, Karolin ; Goergen, Helen ; Hitz, Felicitas ; Zijlstra, Josée M ; Greil, Richard ; Markova, Jana ; Sasse, Stephanie ; Fuchs, Michael ; Topp, Max S ; Soekler, Martin ; Mathas, Stephan ; Meissner, Julia ; Wilhelm, Martin ; Koch, Peter ; Lindemann, Hans-Walter ; Schalk, Enrico ; Semrau, Robert ; Kriz, Jan ; Vieler, Tom ; Bentz, Martin ; Lange, Elisabeth ; Mahlberg, Rolf ; Hassler, Andre ; Vogelhuber, Martin ; Hahn, Dennis ; Mezger, Jörg ; Krause, Stefan W ; Skoetz, Nicole ; Böll, Boris ; von Tresckow, Bastian ; Diehl, Volker ; Hallek, Michael ; Borchmann, Peter ; Stein, Harald ; Eich, Hans ; Engert, Andreas
Source
In The Lancet 11-17 April 2015 385(9976):1418-1427
Subject
Primary Research Articles
Language
ISSN
0140-6736